Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When did they last increase the float?
Is that the consensus, an fda decision in December
The TESICO is still running https://clinicaltrials.gov/ct2/show/NCT04843761?term=NCT04843761&draw=2&rank=1
My opinion, THIS study which is triple blinded will result in an actionable result. It’s been running for six full months now.
Next opinion
This is a compound looking for a revenue stream for 30 years or so
The number of ballots that came in after Election Day were in the low thousands. As per Alitos order those ballots were segregated.
Because EVERYONE knew to get their ballots in early this case pertains to very few ballots and cannot affect the pa election in any way.
Still looks good
Interesting
50 and 200 day ma are converging for the V.I.P. Maker.
I thought I was posting on another board. Sorry
There are two possible roadblocks, a delayed readout and of course a negative readout. Range bound then up more than likely
The channel on this one is 3.12 to 4.58. After that acutely I think it is 60 /40 to go down first with further action depending on how they raise the hundreds of millions to get the vaccine close. Cepi, OWS, WHO, and a few other acronyms or by selling stock. The first pops the stock, the second probably not since two billion shares are already out.
A GBM win would be historically lucrative. High grade gbm is currently a death sentence extended only slightly by recent rx
Hep b Vaccine will bring in cash
I plan to re-evaluate at $3.12
Nothing short of a pr will make the pps move until it’s been in the channel for awhile.
Other ancillary rx look more promising short term to the trading account
Up trending flag
When the 50 day ma approaches the mid 4s and the bollinger bands narrow the 10x move will be over and we will go up. Unless a negative pr prints
If you are two weeks free of say pneumonia then you are well on the road to recovery. Given that you have to get sick and that takes time and the COVID does not just disappear, I would think that 6 weeks is involved and not just the 30 days they are monitored.
And there is every reason to remain positive here. Based on the daily chart the Bollinger bands will converge, the 50 day MA will increase to say the mid 4s and then we will go up in a serious way.
Until then we should continue going up incrementally.
As long as the pps is in the range of the upright flag however the pattern is intact and the pps will more than likely be going up.
All of the attention is great for the stock.
First of all, you guys get up WAY too early
This one is going to run. Early signs are very good for approval. As long as that continues, we are green.
A biologic is expensive in the market. VIP is a biologic.
There are two billion shares, and so the market cap is 1.3 Billion dollars. I can see six billion dollars in market cap or so as we get closer to emergency use.
There is a clear path to three dollars or so in pps
Pre reverse split
Their product will not be ready until WAY into 2021 if that. Phase 1 starts at the end of 2020 and they are not part of OWS.
This will lead to a lack of attention while bettors are waiting. Short term is positive due to PRs.
One cannot know about the market in 2022 I believe.
Biotech is great, because you find a good product and wait for the extremely long period between PRs, usually and then make your bet on final approval for very little money.
Vaccines for COVID are not hard relatively speaking
It all depends on the R0.
The LATEST measure of infectivity is 5.7, see Los Alamos article published in the July CDC.
IF this virus is THAT infective then a herd immunity of upwards of 90% may be required before the pandemic ceases. If them FIRST measures of R0 are correct somewhere around 60% herd immunity will be required.
In the second case this will be over before vbiv finishes it's trial, in the first case we will be treating this for several years.
???
The virus circulates until it no longer finds a host. If it is very easy for the virus, it will infect 5.7 people.
If it is not as infective, then it will infect 2-3 people.
Measles is 12. Extremely infective and so you get outbreaks every once in awhile even though all are legislated to get vaccinated.
Despite the recent article I mentioned most authorities are basing their predictions on the lower R0
Not being anything more than a regular Joe, I am not sure, but I am a very well informed investor of biotech.
Regardless of all that the time between PRs will tank any pre revenue biotech.
There is no way to know where the vaccines of vbiv will perform in people until they get to people
So time, and lower herd immunity will tank the stock. Only a need for a high herd immunity will bring riches to vbiv.
MY OPINION is that vbiv will be viable because of high infectivity.
Reasonable peak followed by a return to say a modest PPS followed by a prolonged uptrend is my opinion.
I put the last part of that prediction at 60 percent which is high for biotech.
This stands in stark comparison to the stock in play when we first met which was just in play with complete trash.
I made my a lot of money by getting out at 18 cents per reverse split.
As always just my opinion.
Unlike the example VBIV will go down and stay down because there is too much time before anything can happen with the positive prs. Then the pps will move on the PRs.
A desert of PRs always tanks ore revenue biotech.
Frankly, VBIV already did peak and got revived by the Motley article. This will not last long so follow the chart and if it breaks the 50 day MA again, sell.
The price WILL go up, that is not the point. In the end it is going back down.
Ditto
This one is off the beaten path. The study starts at the END of the year, that will be when folks are either getting vaccinated or making plans to do so. Vaccines available in the first quarter of 2021 will win. REGARDLESS of the temp needed to administer.
Mountains will be moved to get out the vaccines.
I see
That may pop the stock if there had not been 40 years of Hep B vaccine. Now, VBIV is in play so you never know it may pop the stock.
I got my Hep B vaccine in 1983.
If the presentation was on the vaccine update then I would buy and buy and buy some more.
The pps is ABOVE the 50 day MA, and so if that holds we are going UP. That was not the case earlier in the day.
Tomorrow is Saturday in my area.
???
BUY in the TWOs
You will be AVERAGING DOWN, before it goes back up again. I will think about buying this one in the TWO DOLLAR RANGE.
Now 13000 trades.
This is why I love to trade Biotech.
One dose - a positive statement
Not in Warp speed - given the HUGE market and the unknowns between here and in approval, AND the need to RE TREAT each year or so for COVID 19, there is more than enough room for an approvable vaccine or ten.
Minus 94 degrees pertains to the Competition, it could pertain to VBIV, but I have no data there - Possibly a positive if not then it could kill a vaccine because there is only a tiny fraction of the US that can accomodate MINUS 94.
This news was instantly shorted and the pps closed near a LOW of the day. CMF turned extremely negative and so, maybe the PPS will go lower.
Motley is the best stock picker and they are also widely read hence the HUGE volume.
900 million in market cap, this morning, and 9500 TRADES already, is interesting. The first is a positive and volume does follow price, down in this case.
it will be rocky and then it will declare itself based on the PRs. overall, ALL COVID 19 stocks are getting sold right now. NET.
I sold the basket of vaccines the day the charts broke a little while ago.
Yes, I would NOT buy VBIV today, it has a ways to go before it can be bought.
Beats me if this is going Up or down. GLTA
There was an article about two competitors requiring storage temperature of MINUS 94 degrees F. MUCH Colder than a witches teat.
These up until now EXPERIMENTAL vaccines ( RNA ) are turning out to have exotic requirements, two doses and VERY cold storage.
If VBIV footprint is half the size that would be significant.
Of course, there are HUGE orders ALREADY in for the TOP FIVE companies that are part of Operation Warp Speed. VBIV is NOT part of Operation Warp speed.
It is good to keep up the interest in rlftf, however after a ten fold move, the pps needs time to distribute before the next accumulation.
The chart gets soft now and then but is otherwise building up potential energy for the explosion.
The next move will come all of a sudden, and so those who are in it will benefit, hopefully.
at .55 at the close.
Put in orders for .5, .45. and .4 and see if you catch any fish.
Check in at breakfast lunch and dinner to see just how many fish got caught in the net.
Rinse repeat until the stock goes to dollars.
Buy stocks on sale, why not. I know I rarely follow my own advice but I can say that I have several other stocks that are on sale right now.
Buy low sell high. This one will take a few weeks or more, instead of a few days.
RLF DOES show promise, but it will most definitely lanquish until some PR makes it bounce, preferably the PR that says the folks who got the drug survived and so on.
Suggest averaging down before what seems to be the inevitable pop.
What were holiday sales?
Where is the data?
I too check in every once in awhile.
I first bumped into this stock when it was very low. Stopped out on a very busy day for a three bagger and did not get the full ten bagger. Oh well.
I see the DOWNLOADS for VIVA are over a million.
However everything else is a mess. How can that be?
I see it is the 69 cent exchange.
.69 cents a share. Uplist to the jiberlywhipit exchange?
Where is the fourth quarter sales info?
Where?
I just did a review.
Link please
Since October.
A bunch of S1s.
Show me the sales
When would product ship, before or after the holiday.
The holiday is done now.
The pps is . 003.
Not sure why, just the facts.
Last pr was Oct.
Uplist uplist uplist.
RS.
If something is going to happen to sales it will happen next Oct.
The season starts then as people order and cases are shipped for the holidays.
The holiday season certainly does not start now.
If they announce millions of dollars of sales great.
They would have done that by now.
What were holiday sales?
Apparently not much.
Who wouldn't buy Christie Brinkley?
Something is wrong, its been at least two holiday seasons.
My tv provider has ONE Million downloads.
OTTV - 10000
You want to fire Christie Brinkley?
As of the recent filing, the revenue was up, but nothing in the range being talked about. Not close. Not in the revenue or the receivables.
You would think so. They have a highly rated product, probably the top celebrity to market to a certain age group, and four new products.
Time has allowed for numerous reviews. The average review is quite good.